although public commentari limit provid intra-quart
visibl neg impact elect surgeri volum reflect
comment updat forecast beyond recogn
revis best guess junctur ultim unlik accur
also adjust price target
revis estim reflect neg impact
updat forecast across coverag univers believ
number inher aggress consid current environ heavili
weight toward elect surgeri therefor one compani need
updat use public comment compani file deriv revenu estim
geographi assum account sale lat
france/italy/spain/germany/uk combin switzerland/benelux/nordic/centr
europe/middl east/africa combin japan china south
korea australia/new zealand/oth asia pac combin
region impact assumpt hospit across adopt
widespread elect surgeri postponement/cancel polici sinc mid-march
assum sell day impact elect surgeri
postpon western europ revenu assum elect procedur
volum also shut mid-march itali elimin elect procedur
begin march elect procedur impact asia
data point manag assum elect procedur
volum shut china japan south korea total revenu combin
februari march forecast shortfal origin revenu
estim stress call worst-posit name
large-cap med tech group instead simpli use manag recent comment
start point refin project work across coverag univers
region impact assumpt assum hope
conserv stifl year elect surgeri volum part
estim sell day impact
surgeri postpon region outsid asia asia assum
procedur postpon expect procedur
region recoveri start end year
continu forecast hit previou revenu estim
recoveri assumpt took simplist high-level approach
revenu build assumpt believ hospit begin recov
return histor product level patient backlog provid
tailwind util could provid releas valv procedur volum capac
constraint forecast organ revenu growth base
acceler organ revenu growth
oper expens estim also challeng project base current
inform think manag tri posit compani come
end crisi posit strength therefor assum
invest sale market modestli temper turn
expect recov sg leverag return
pleas see page report import disclosur
market perform rate stem zbh outsiz exposur reconstruct joint
market make compani heavili reliant hip knee implant year
weak recon market cap sale growth biomet merger continu
roll-out persona knee system better-posit captur market share
strengthen recon busi howev recent suppli issu delay zbh return
market growth rate remedi suppli constraint demonstr sustain
improv recon well compani non-recon area key
full launch rosa knee
updat launch time rosa spine
hip
elimin exist suppli constraint
resolut suppli constraint line
manag guidanc
faster-than-expect resolut
continu success integr
continu stabil global
merger acquisit synergi
anticip
deterior global recon market
market share loss knee hip
design sell reconstruct spinal trauma devic compani also
biolog sport medicin dental bone heal microfix relat surgic devic
product portfolio manag oper three geograph segment
america consist unit state includ north central
south american market europ consist europ includ middl east
africa market asia pacif compris japan australia select market
zimmer merg biomet june greatli expand orthoped scale
revis price
updat model shown figur page account
estim chang well signific declin stock market valuat multipl
recent week weve lower price target previous
new target reflect price-to-earnings multipl appli forward ep estim zbh
manag done commend job recent quarter especi effort
acceler organ revenu growth better posit compani margin expans
initi continu temporarili disrupt
pandem await clariti recoveri path remain market perform
compani report thomson eikon cowen compani
mm except oper biomet oper cowen
compani report cowen compani
mm except ex-fx ex-fx ex-fx ex-fx ex-fx ex-fx ex-fx ex-fx ex-fx spine ex-fx ex-fx ex-fx ex-fx revenu less growth impact ex-fx growth day day impact report ex-fx ex-fx ex sell day cowen
valuat methodolog primarili base current year forward year ev/sal
ev/ebitda multipl well current year forward price-to-earnings multipl total return/p
ratio market cap/fre cash flow metric dividend yield comp
orthoped industri risk continu util pressur account
organ play bigger role health care deliveri competit dynam global
potenti regulatori delay reject failur devic clinic trial econom
sensit price pressur and/or weaken consum demand develop market
econom and/or polit uncertainti emerg market intellectu properti
deeper util pressur recon busi us europ worsen
competit dynam global potenti regulatori delay reject failur
devic clinic trial econom sensit price pressur and/or weaken
demand develop market econom and/or polit uncertainti emerg
market fluctuat foreign exchang rate
author research report herebi certifi view express research report accur reflect person view subject
secur issuer ii part compens relat directli indirectli specif recommend view express report
